Clinical trial
The Efficacy and Safety of Escitalopram for Depression in Multiple Sclerosis
NCT00151294 · Weill Medical College of Cornell University, Other · Terminated
Key facts
| NCT number | NCT00151294 |
|---|---|
| Title | The Efficacy and Safety of Escitalopram for Depression in Multiple Sclerosis |
| Official title | A Double-Blind, Placebo-Controlled Investigation Into the Safety and Efficacy of Escitalopram for Depression in Multiple Sclerosis |
| Lead sponsor | Weill Medical College of Cornell University, Other |
| Collaborators | Forest Laboratories Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Depression, Multiple Sclerosis |
| Intervention type | Drug |
| Interventions | escitalopram oxalate antidepressant |
| Enrollment | 20 |
| Start date | Nov 1, 2004 |
| Completion | Oct 1, 2006 |
| First posted | Sep 8, 2005 |
| Last update posted | Sep 14, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: